MABECO · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of MABECO is 0.2% (very low). The 2024 annual accounts show equity of €13k and a net result of €3k. Its solvency ranks better than 7% of 6584 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.

Signals

1 signal · with evidence

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 7% of 6584 sector peers (2024).

View the sector comparison

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

How we compute the deadline

There is a single filed set of accounts, closing on 31-12. That date is certain, but one observation does not establish the rhythm (a first financial year may run longer than twelve months), so we project no following year. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2024	31-07-2025	30-06-2025	31 d early	2025-00196860

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

Young company

Founded in 2023, under 3 years, statistically higher risk.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€3k

Working capital€19k

CSV export

Annual accounts & ratios

Source: NBB · 2024

Annual accounts filed on 30-06-2025 with the NBB · fiscal year 2024 · micro

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	3.3%	66.7%	better than 7% of 6584 sector peers
Net result	€3k	€46k	better than 12% of 6578 sector peers
Equity	€13k	€79k	better than 14% of 6584 sector peers
Gross operating margin	€53k	€78k	better than 36% of 6586 sector peers
Total assets	€396k	€154k	better than 82% of 6587 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Highlight YoY changes (±10%)

Fiscal year	2024
Deposit	micro
Revenue	-
EBITDA	€51k
Net profit	€3k
Cash flow	€46k
Staff costs	-
Income taxes	€1k
Dividends	-
Total assets	€396k
Equity	€13k
Debt	€383k
of which ≤ 1y	€33k
of which > 1y	€350k
Working capital	€19k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	1.58
Quick ratio	1.06
Working capital ratio	4.8%
Solvency	3.3%
Debt / equity	29.22
Long-term debt ratio	26.73
Interest coverage	11.42
Gross margin	-
Net margin	-
ROA	0.8%
ROE	23.6%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €344k · 87.0% Current assets €52k · 13.0%

Equity & liabilities

Equity €13k · 3.3% Debt €383k · 96.7%

Full annual accounts (24 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€396k
Fixed assets	21/28	€344k
Tangible fixed assets	22/27	€341k
Financial fixed assets	28	€4k
Current assets	29/58	€52k
Stocks & contracts in progress	3	€17k
Amounts receivable within one year	40/41	€734
Cash & bank	54/58	€34k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€396k
Equity	10/15	€13k
Contributions / capital	10/11	€10k
Reserves	13	€3k
Amounts payable	17/49	€383k
Amounts payable after one year	17	€350k
Amounts payable within one year	42/48	€33k
Trade debts payable within one year	44	€4k
Income statement
Gross operating margin	9900	€53k
Operating result	9901	€8k
Financial income	75	€914
Financial charges	65	€4k
Result before taxes	9903	€5k
Income taxes	67/77	€1k
Net result for the period	9904	€3k
Result to be appropriated	9905	€3k

Ratios computed by Checked.

Health barometer

FY 2024 · computed

73 / 100 Healthy

050100

Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Directors

Directors & mandates

1 director

3 of this company's 3 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing below: a director who resigned there may therefore still show here as sitting. See the acts under Publications.

Current directors & mandates

Manon Leroij
Director
State Gazette act 25066444 (23-05-2025)

Current
22-04-2025 → present

Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary	Activiteiten van medisch specialisten(86220)
Legal form	Private limited company(610)
Incorporation	20-10-2023
Status	Active
Postal code	2550

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

8 companies at this address See who is registered here

Establishment units

1 location

Prunus Ventures

Molenstraat 54, 2550 KontichActiviteiten van medisch specialisten

since 20232.351.018.692

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area647 m²

Buildings1

Building footprint219 m²

Volume (LiDAR)1,860 m³

Tallest building13.5 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)